Pharma Opportunity Certificate
2020 will go down in history as the year of Covid-19. What initially seemed to be a small epidemic limited to China, has spread out to the entire globe, seriously affecting societies and economies while setting off crisis on all imaginable levels. Get involved in the combat against the Coronavirus and invest in companies that are seeking solutions to put an end to this pandemic.
Pharma Opportunity
ISIN: CH0521605003
There has been an unprecedented eruption of global pharmaceutical research and development related to COVID-19. More than 330 clinical studies and 80 vaccine candidates are currently under review. Big pharma and biotech companies are working to find a drug to manage or defeat COVID-19. With the Pharma Opportunity Certificate, you invest in the performance of companies that are actively working on medicines to combat the coronavirus by developing vaccines or treatments.
Benefits
Increased growth potential
Broad diversification
Professionally and actively managed
Traded on the SIX Swiss Exchange
CHF 9.- flat transaction costs (excluding stock exchange and real time fees)
Start trading now
Want to get ahead of the curve?
Subscribe to our Newsletter to receive market news, trade ideas & new themes